![Maria Lacerca-Allen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maria Lacerca-Allen
Directeur/Membre du Conseil chez
SHIELD THERAPEUTICS PLC
Fortune : 14 453 $ au 31/07/2026
Profil
Currently, Maria Fabiana Lacerca-Allen is Director at American Red Cross Bay Area and Independent Non-Executive Director at Shield Therapeutics Plc since 2021.
Former roles include Chief Compliance Officer & Senior Vice President at Aimmune Therapeutics, Inc. from 2020 to 2023; Compliance Director-Latin America & Canada at Bristol Myers Squibb Co.; Chief Compliance Officer & Senior Vice President at Mylan, Inc.; Chief Compliance Officer at Mylan Laboratories, Inc. in 2007; Chief Compliance Officer at Elan Corp.
Plc from 2012 to 2014; Non-Executive Director at Arthrocare Corp.
from 2013 to 2014.
Education includes graduate studies at the University of California, Los Angeles and graduate and doctorate degrees from Universidad de Buenos Aires.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2025 | 271 886 ( 0,03% ) | 14 453 $ | 31/07/2026 |
Postes actifs de Maria Lacerca-Allen
| Sociétés | Poste | Début |
|---|---|---|
| SHIELD THERAPEUTICS PLC | Directeur/Membre du Conseil | 10/05/2021 |
American Red Cross Bay Area | Directeur/Membre du Conseil | - |
Anciens postes connus de Maria Lacerca-Allen
| Sociétés | Poste | Fin |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | Compliance Officer | 01/05/2023 |
| ARTHROCARE CORPORATION | Directeur/Membre du Conseil | 29/05/2014 |
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Compliance Officer | 24/04/2014 |
Mylan Laboratories, Inc.
 Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Compliance Officer | 02/10/2007 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Formation de Maria Lacerca-Allen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Health Technology |
Arthrocare Corp.
 Arthrocare Corp. Medical SpecialtiesHealth Technology Manufactures medical devices for sports medicine and ear, nose & throat problems | Health Technology |
Mylan, Inc.
 Mylan, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures generic pharmaceuticals | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universidad de Buenos Aires
 Universidad de Buenos Aires Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Red Cross Bay Area | |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
Shield Therapeutics Plc
 Shield Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and commercializes late stage pharmaceutical products | Health Technology |
